Biosimilars and GLP-1 medications are reshaping the pharmaceutical landscape, presenting both opportunities and challenges for IDN pharmacy operations. As adoption accelerates and demand surges, understanding the clinical, financial, and operational implications of these drug categories has become essential for effective pharmacy management. In this session, explore how these medications are impacting formulary decisions, cost structures, patient access, and overall supply chain strategy.

Join pharmacy leaders as they share real-world experiences managing biosimilar integration and GLP-1 demand, offering practical insights into optimizing utilization while controlling costs and maintaining quality outcomes.

Learning Objectives:
1. Analyze the financial and clinical impact of biosimilar adoption on formulary management and total cost of care within your organization.
2. Evaluate strategies for managing GLP-1 drug demand, access, and utilization amid supply constraints and reimbursement challenges.
3. Identify operational considerations for integrating biosimilars into existing workflows, including clinician education and patient transition protocols.
4. Develop approaches to balance cost savings opportunities with quality, safety, and patient access priorities across both drug categories.

Central pharmacy services are evolving from basic compounding and distribution functions into strategic assets that drive efficiency, quality, and cost savings across entire health systems. As IDNs seek greater standardization and economies of scale, centralized pharmacy models are taking on expanded responsibilities and emerging as critical components of enterprise-wide supply chain strategy. In this session, discover how leading organizations are leveraging central pharmacy to enhance patient care while optimizing operational and financial performance.

Hear from IDNs that have successfully scaled their central pharmacy operations to provide greater value, improved compliance, and enhanced service delivery across multiple facilities.

Learning Objectives:
1. Recognize emerging models for central pharmacy services that extend beyond traditional compounding to support broader organizational objectives.
2. Compare centralized versus decentralized pharmacy approaches to determine optimal structure based on organizational size, complexity, and strategic goals.
3. Apply best practices for scaling central pharmacy operations to achieve standardization, cost reduction, and quality improvement across an IDN.
4. Design implementation strategies that address regulatory compliance, workflow integration, and stakeholder engagement when expanding central pharmacy services.

The pharmaceutical supply chain faces unprecedented disruption from geopolitical tensions, tariff policies, manufacturing vulnerabilities, and market volatility. These forces create significant challenges for IDN pharmacy leaders tasked with ensuring medication availability while managing costs and maintaining patient safety. In this session, examine the disruptive trends reshaping the pharmaceutical marketplace and explore strategies for building supply chain resilience in an uncertain environment.

Industry experts will discuss how organizations are responding to disruption through strategic sourcing, inventory optimization, supplier diversification, and collaborative partnerships that strengthen supply chain stability.

Learning Objectives:
1. Identify key disruptive forces, including tariffs, geopolitical factors, and manufacturing shifts, that are impacting pharmaceutical supply chain stability.
2. Evaluate risk mitigation strategies that protect against drug shortages, price volatility, and supply chain disruptions.
3. Apply inventory management and sourcing techniques that balance cost efficiency with supply assurance in a volatile marketplace.
4. Formulate resilience-building approaches that leverage supplier relationships, technology, and cross-functional collaboration to stabilize pharmaceutical supply chains.

Federal policy decisions have profound implications for IDN pharmacy operations, reimbursement models, and strategic planning. From 340B program integrity to comprehensive legislative packages, rural hospital support, and FDA regulatory changes, the policy landscape continues to evolve rapidly. In this session, hear from a healthcare attorney who will break down the latest developments from Washington and translate complex policy changes into actionable insights for pharmacy and supply chain leaders.

Gain clarity on how recent and pending federal actions may impact your organization’s pharmacy operations, financial performance, and compliance obligations.

Learning Objectives:
1. Interpret current legislative and regulatory developments impacting the 340B Program and their implications for eligible entities.
2. Assess how comprehensive healthcare legislation and rural hospital initiatives may impact IDN pharmacy strategy and operations.
3. Recognize recent FDA policy changes and enforcement priorities that impact drug access, supply chain management, and compliance requirements.
4. Analyze international drug pricing policies that impact domestic drug pricing and reimbursement, including under federal health care programs and commercial insurance plans.

Payment policy changes can significantly impact pharmacy revenue, reimbursement rates, and overall financial viability for IDNs. As new rules take effect in 2026, understanding the details and implications is critical for pharmacy and supply chain leaders responsible for financial planning and operational strategy. In this session, break down the most important payment rule changes on the horizon and explore how leading organizations are preparing to adapt.

Learn which specific payment policies will impact your bottom line and what steps you can take now to mitigate financial risk while maintaining quality patient care.

Learning Objectives:
1. Identify the most significant 2026 payment rule changes impacting pharmacy reimbursement, drug pricing, and IDN financial performance.
2. Calculate the potential financial impact of new payment policies on your organization's pharmacy operations and revenue streams.
3. Distinguish between payment rules requiring immediate action versus those allowing longer-term strategic adjustment.
4. Formulate adaptive strategies that optimize reimbursement, ensure compliance, and protect financial sustainability under new payment frameworks.

Innovation drives progress in pharmacy operations, and learning from peer organizations offers valuable insights into what's possible. In this session, hear directly from Fairview Health Services as they share recent innovations and strategic developments that have transformed their pharmacy and supply chain operations. Discover practical approaches, lessons learned, and outcomes achieved through their commitment to continuous improvement and forward-thinking leadership.

Explore how one health system is tackling today's pharmacy challenges through creative solutions, technology adoption, and operational excellence initiatives that can be adapted to your own organization.

Learning Objectives:
1. Analyze innovative pharmacy and supply chain strategies implemented by Fairview Health Services and their measurable outcomes.
2. Evaluate the applicability of Fairview's approaches to your own organizational context, considering size, structure, and strategic priorities.
3. Identify key success factors and potential obstacles when implementing similar innovations within your organization.
4. Apply lessons learned from Fairview's experience to accelerate innovation adoption and avoid common implementation pitfalls in your organization.

The landscape facing pharmacy executives today is as diverse as the organizations they serve, yet common threads often emerge when leaders candidly share the obstacles most impacting them. This session creates space for participants to introduce themselves, their organizations, and the strategic challenges currently demanding their attention. Whether navigating workforce constraints, regulatory uncertainty, cost pressures, or operational transformation, this conversation establishes the foundation for meaningful exchange throughout the forum.

Learning Objectives:
1. Identify common strategic and operational challenges facing pharmacy executives across diverse IDN environments.
2. Compare how different health systems are prioritizing competing demands and allocating resources to address critical pharmacy pain points.
3. Recognize emerging trends and pressure points within the pharmacy landscape based on collective insights from participants.
4. Establish connections with peers facing similar challenges to facilitate ongoing collaboration and knowledge sharing beyond the forum.

Drug shortages have become a persistent reality rather than an occasional disruption, fundamentally reshaping how pharmacy executives approach inventory management, supplier relationships, and clinical decision-making. The traditional playbook no longer suffices when unpredictability is the only constant. This session brings together pharmacy leaders to explore how organizations are adapting their strategies, from safety stock optimization and alternative sourcing to clinical protocol adjustments and cross-functional crisis response.

Learning Objectives:
1. Evaluate inventory management approaches that balance cost efficiency with supply assurance in an environment of chronic drug shortages.
2. Analyze predictive and reactive strategies for shortage mitigation, including technology enablement, supplier diversification, and therapeutic substitution protocols.
3. Compare organizational models for shortage response and determine which governance structures and decision-making frameworks prove most effective.
4. Formulate enhanced inventory and shortage management strategies informed by collective experience and emerging best practices from peer organizations.

Pharmacy operations face intensifying financial pressure from every direction—reimbursement reductions, drug cost inflation, regulatory changes, and shrinking margins that threaten sustainability. Revenue cycle optimization is no longer a back-office concern but a strategic imperative requiring executive attention and cross-functional coordination. This session examines how pharmacy leaders are navigating financial challenges while preserving access to essential medications and maintaining operational integrity.

Learning Objectives:
1. Identify critical revenue cycle vulnerabilities and margin compression drivers affecting pharmacy financial performance across IDN settings.
2. Assess strategies for revenue capture optimization, charge integrity, and reimbursement maximization without compromising compliance or patient access.
3. Distinguish between short-term financial interventions and sustainable approaches to margin protection based on organizational experience and outcomes.
4. Develop financial resilience strategies that address both immediate pressures and longer-term sustainability challenges facing pharmacy operations.